RSLS - ReShape Lifesciences Inc. (RSLS) Q1 2024 Earnings Call Transcript
2024-05-17 20:57:06 ET
ReShape Lifesciences, Inc. (RSLS)
Q1 2024 Earnings Conference Call
May 15, 2024, 16:30 ET
Company Participants
Michael Miller - Investor Relatons
Paul Hickey - President, CEO & Director
Thomas Stankovich - CFO
Conference Call Participants
Presentation
Operator
Good afternoon, and thank you for joining the ReShape Lifesciences First Quarter 2024 Conference Call. I would like to turn the call over to Michael Miller from Rx Communications.
Michael Miller
Good afternoon, and thank you for joining the first quarter 2024 ReShape Lifesciences earnings call. I'm pleased to be joined today by Paul Hickey, President and Chief Executive Officer, and Tom Stankovich, Chief Financial Officer. Paul will provide an overview and update on the company's activities, and Tom will review the financial results for the period, we will then turn the call back over to Paul for some closing remarks, after which we will open up the call to question and answer session.
As a reminder, this conference call as well as ReShape Lifesciences SEC filings and website, including the investor information section of the website contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those discussed due to known and unknown risks, uncertainties and other factors....
ReShape Lifesciences, Inc. (RSLS) Q1 2024 Earnings Call Transcript